NYSEMKT: IGC
Igc Pharma Inc Stock Ownership - Who owns Igc Pharma?

Insider buying vs selling

Have Igc Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James P. MoranDirector2024-09-25588,235$0.34
$200.00kBuy

1 of 1

IGC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IGC insiders and whales buy or sell their stock.

IGC Shareholders

What type of owners hold Igc Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bradbury Strategic Investment Fund A Cayman Islands Registration No Cr3598576.27%5,000,000$1.42MInsider
Ram Mukunda5.98%4,761,763$1.35MInsider
Db Zwirn Co LP1.86%1,485,404$420.37kInsider
James P. Moran1.63%1,296,569$366.93kInsider
Ranga C. Krishna1.34%1,068,461$302.37kInsider
Richard K. Prins1.31%1,042,917$295.15kInsider
Claudia Grimaldi1.30%1,037,154$293.51kInsider
Steven Michael Oliveira0.97%772,196$218.53kInsider
Blackrock Inc0.88%703,798$199.17kInstitution
Sudhakar V. Shenoy0.87%695,000$196.69kInsider

1 of 3

IGC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IGC3.56%23.32%Net Buying
PULM4.56%95.44%
GRCE20.59%69.46%
LGVN2.98%97.02%Net SellingNet Selling
QTTB34.83%65.17%Net Buying

Igc Pharma Stock Ownership FAQ

Who owns Igc Pharma?

Igc Pharma (NYSEMKT: IGC) is owned by 3.56% institutional shareholders, 23.32% Igc Pharma insiders, and 73.12% retail investors. Bradbury Strategic Investment Fund A Cayman Islands Registration No Cr359857 is the largest individual Igc Pharma shareholder, owning 5.00M shares representing 6.27% of the company. Bradbury Strategic Investment Fund A Cayman Islands Registration No Cr359857's Igc Pharma shares are currently valued at $1.43M.

If you're new to stock investing, here's how to buy Igc Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.